When Your Body Needs Help Healing Itself

Regenerative cellular therapy works with your body’s own repair signals — using ethically sourced human cellular and tissue-based products (HCT/Ps) to support the environment where healing happens. At Longitude Life it’s physician-directed and selective: not a menu of injections, and not everyone qualifies. Every protocol is built only on the most rigorously sourced, tested, and documented biologics available in the United States.

What It Can Help With

Aching, worn joints. Knee, shoulder, hip, elbow, wrist, or ankle — where cartilage wear, soft-tissue injury, or age-related degeneration is the issue. Placental-derived extracellular matrix (collagens, growth factors, native mesenchymal stem cell populations), sometimes paired with exosomes, provides a scaffold and signaling environment that may support your body’s natural repair. A common option for people exploring alternatives before or after surgery.

Spinal disc and soft-tissue concerns. Image-guided (fluoroscopic or ultrasound) intradiscal, epidural, or facet-joint delivery, where the extracellular-matrix scaffold may support the disc and the surrounding tissue environment.

A recovery that’s slowed down. IV exosome infusions distribute nano-sized vesicles (30–150 nm) carrying bioactive cargo systemically; research suggests they participate in cell-to-cell communication and may support immune modulation and tissue maintenance. Administered under direct medical supervision.

Neurological tissue support (investigational). Intranasal exosomes may bypass the blood-brain barrier to reach the central nervous system more directly — offered as an investigational option after thorough evaluation.

Thinning hair. Scalp micro-injections of MSC-derived exosomes and extracellular matrix, often with microneedling — exosomal cargo (VEGF, PDGF-AA, IGF) may support circulation around the follicle and the signaling tied to the growth cycle. For early-to-moderate thinning, as a non-surgical option.

Aging skin. Exosome-based facial protocols, paired with microneedling or fractional laser, deliver vesicles that may support fibroblast activity, collagen synthesis, and natural turnover — without fillers or neurotoxins. Includes facial infusions, post-procedure recovery support, under-eye and décolletage rejuvenation, and scar and texture refinement.

Also available: soft-tissue support (tendons, ligaments), wound-healing support, and sexual health protocols.

Done Safely, Sourced Right

The biggest risk in regenerative medicine isn’t the biology — it’s where the material comes from. Ours is built to take that risk off the table:

• U.S. labs, top credentials. FDA-registered, AATB-accredited, CLIA-certified tissue banks with cGMP processing and multiple FDA-approved INDs — including an early, uncommon UC-MSC + exosome combination IND for IV use.
• Ethically sourced, minimally manipulated. Perinatal tissue (placenta, umbilical cord, Wharton’s Jelly) from healthy, full-term C-section deliveries via direct OBGYN partnerships — processed for homologous use per FDA 21 CFR 1271, preserving regenerative capacity.
• Rigorous screening. Triple-layer donor screening, three-generation family medical history, comprehensive pathogen testing, and a 14-day lot quarantine before any product is released.
• Full chain of custody. 100% documented from delivery room to clinic — not material of uncertain provenance passed through intermediaries.
• Why not offshore. Clinics in Mexico, Colombia, and parts of the Caribbean often use culture-expanded cells of uncertain origin that lose potency with each passage, with screening and oversight that vary widely — frequently $15,000–$50,000+ including travel, and complications handled far from home.

Perinatal tissue is also naturally well-tolerated and doesn’t require donor–recipient matching — an advantage over self-derived approaches that need an invasive harvest.

Is Regenerative Therapy Right for You?

Not everyone is a candidate, and our physician-led evaluation looks at your complete health picture first.

You may be a candidate if you:

• Have persistent joint discomfort that hasn’t responded to conventional approaches
• Are weighing alternatives before or after surgery
• Are seeking support for spinal disc or soft-tissue concerns
• Are interested in whole-body support through IV exosome protocols
• Are interested in neurological tissue support through investigational intranasal protocols
• Want a non-surgical, biologic-based option for hair restoration or skin rejuvenation

You may not qualify if you have:

• Active infections, certain autoimmune conditions, or active malignancies
• Uncontrolled systemic conditions that may compromise safety
• A medical history the physician determines presents elevated risk

The Big 3

• Physician-directed and selective — not everyone qualifies, and we’ll tell you honestly.
• Sourced only from FDA-registered, AATB-accredited, CLIA-certified U.S. labs, with full chain of custody.
• These therapies are investigational — we set realistic expectations before anything begins.

Find Out If You’re a Candidate

The first step is an honest evaluation — whether regenerative therapy is right for you, and what to realistically expect.

These products and therapies are investigational. They have not been approved by the FDA for the treatment, cure, or prevention of any disease or medical condition. Individual results may vary. Not all patients qualify for treatment. A comprehensive medical evaluation is required before any regenerative protocol is initiated. Regenerative cellular therapy products discussed herein are human cellular and tissue-based products (HCT/Ps) regulated under FDA 21 CFR Part 1271, processed for homologous use and minimally manipulated per applicable FDA guidance. References to clinical trials, research, or published literature are provided for informational context and do not constitute claims of efficacy for any specific product or protocol offered at this clinic.